However, another study reported that anti‐VEGF therapies reduced ADC values in the intracranial metastasis model of breast cancer due to the reduction in tissue perfusion.21 Remarkably, for patients with abdominal metastases tumor, the ADC values increased significantly after treatment with VEGF inhibitors.22 Therefore, the variation in ADC values after successful anti‐angiogenesis treatment of TNBC remains unclear. Here, VEGFA is linked to breast carcinoma.